• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Intravenous thrombolysis for acute ischemic stroke during two COVID-19 outbreaks in China: Wuhan pandemic and Beijing pandemic
The COVID-19 pandemic has had an impact on the emergency department (ED). Door-to-needle time (DNT) could be prolonged for intravenous thrombolysis (IVT) treatment. We aimed to investigate the impact of two CO...
Source: BMC Neurology - May 25, 2023 Category: Neurology Authors: Guangshuo Li, Shang Wang, Chuanying Wang, Yahui Hao, Yunyun Xiong, Zeyu Ding and Xingquan Zhao Tags: Research Source Type: research

Viruses, Vol. 15, Pages 1235: Ischaemic Stroke Occurring in a Patient Treated with Monoclonal Antibodies for COVID-19
In conclusion, among several side effects that have been described during the treatment of COVID-19 with sotrovimab, ischaemic stroke was not reported. Therefore, we here report a rare case of ischaemic stroke with early clinical manifestation after the administration of sotrovimab for the treatment of moderate COVID-19 in an immunocompromised patient for the first time.
Source: Viruses - May 25, 2023 Category: Virology Authors: Antonio Lobasso Ciro di Gennaro Maria Rita Poggiano Antonio Vasta Raffaele Angelo Nicola Ranucci Roberto Lobianco Anna Giacoma Tucci Enrico Cavagli à Pierpaolo Di Micco Tags: Case Report Source Type: research

Impact of the COVID-19 pandemic on acute stroke care: An  analysis of the 24-month data from a comprehensive stroke center in Shanghai, China
CONCLUSIONS: During the 24 months of COVID-19, a prolongation of stroke onset to hospital arrival and to intravenous rt-PA administration times were noted. Meanwhile, acute stroke patients needed to stay in the ED for a longer time before hospitalization. Educational system support and process optimization should be pursued in order to acquire timely delivery of stroke care during the pandemic.PMID:36890633 | DOI:10.1111/cns.14148
Source: CNS Neuroscience and Therapeutics - March 8, 2023 Category: Neuroscience Authors: Qimin Hu Yiming Hu Yue Gu Xiaoyan Song Yijue Shen Haiyan Lu Li Zhang Peifeng Liu Guodong Wang Chunni Guo Kan Fang Qiaoshu Wang Source Type: research

IJERPH, Vol. 19, Pages 2278: The Impacts of COVID-19 on Healthcare Quality in Tertiary Medical Centers & mdash;A Retrospective Study on Data from Taiwan Clinical Performance Indicators System
IJERPH, Vol. 19, Pages 2278: The Impacts of COVID-19 on Healthcare Quality in Tertiary Medical Centers—A Retrospective Study on Data from Taiwan Clinical Performance Indicators System International Journal of Environmental Research and Public Health doi: 10.3390/ijerph19042278 Authors: Shih-An Liu Chieh-Liang Wu I-Ju Chou Pa-Chun Wang Chia-Ling Hsu Chia-Pei Chen To date, COVID-19 is by far the most impactful contagious disease of the 21st century and it has had a devastating effect on public health in countries around the globe. Elective medical services have declined markedly since the outbreak...
Source: International Journal of Environmental Research and Public Health - February 17, 2022 Category: Environmental Health Authors: Shih-An Liu Chieh-Liang Wu I-Ju Chou Pa-Chun Wang Chia-Ling Hsu Chia-Pei Chen Tags: Article Source Type: research

Telestroke for the Treatment of Ischemic Stroke in Western China During the COVID-19 Pandemic: A Multicenter Observational Study
ConclusionsTelemedicine is effective in improving the thrombolysis administration among patients with IS in Western China. Implementation of the telestroke network should be promoted, especially when access to care is affected by public health emergencies, such as the COVID-19 pandemic.
Source: Frontiers in Neurology - January 31, 2022 Category: Neurology Source Type: research

Outcome After Acute Ischemic Stroke Treatment During Covid-19 Outbreak in South-East Tuscany
Source: Cardiovascular and Haematological Disorders - Drug Targets - January 20, 2022 Category: Cardiology Authors: Acampa, Maurizio Peresso, Valentina Lazzerini, Pietro E. Domenichelli, Carlo Guideri, Francesca Tassi, Rossana Dami, Stefano Marconi, Roberto Iannelli, Giovanni Linoli, Giovanni Peppoloni, Giulia Nocentini, Simone Gallerini, Simone Cartocci, Alessandra Br Tags: Research article Source Type: research

Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
CONCLUSIONS: Our study demonstrates that remdesivir, a novel drug applied to the treatment of COVID-19, does not have a significant association with adverse neurologic or psychiatric reactions in the real-world setting.PMID:34919240 | DOI:10.26355/eurrev_202112_27435
Source: Pharmacological Reviews - December 17, 2021 Category: Drugs & Pharmacology Authors: S Lee J W Yang S Y Jung M S Kim D K Yon S W Lee H-C Kang E Dragioti K Tizaoui L Jacob A Koyanagi J-E Salem K Kostev A Lascu J I Shin J H Kim L Smith Source Type: research

Pages: 1  2  3  4  5  6